C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/47 (2006.01) C12N 5/078 (2010.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01) C07K 7/06 (2006.01) C07K 16/18 (2006.01)
Patent
CA 2696701
Disclosed is a peptide of the following item (A) or (B). Also disclosed is use of the peptide. (A) A peptide comprising the amino acid sequence depicted in SEQ ID NO:1 or SEQ ID NO:2. (B) A peptide which comprises an amino acid sequence having the substitution, deletion, insertion and/or addition of one, two or several amino acid residues in the amino acid sequence depicted in SEQ ID NO:1 or SEQ ID NO:2, and which is capable of inducing a killer T cell.
L'invention porte sur un peptide de l'article suivant (A) ou (B). L'invention porte également sur l'utilisation du peptide. (A) un peptide comprenant la séquence d'acides aminés représentée dans SEQ ID NO : 1 ou SEQ ID NO : 2. (B) un peptide qui comprend une séquence d'acides aminés ayant la substitution, la délétion, l'insertion et/ou l'addition d'un, deux ou plusieurs résidus d'acides aminés dans la séquence d'acides aminés représentée dans SEQ ID NO : 1 ou SEQ ID NO : 2, et qui est capable d'induire un lymphocyte T tueur.
Harao Michiko
Nakamura Yusuke
Nishimura Yasuharu
Tsunoda Takuya
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Oncotherapy Science Inc.
LandOfFree
Cdca1 peptide and pharmaceutical agent comprising the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cdca1 peptide and pharmaceutical agent comprising the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cdca1 peptide and pharmaceutical agent comprising the same will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2088858